Adimmune Corp (Taiwan) Analysis
| 4142 Stock | TWD 21.95 0.25 1.13% |
Adimmune Corp is undervalued with Real Value of 23.69 and Hype Value of 21.95. The main objective of Adimmune Corp stock analysis is to determine its intrinsic value, which is an estimate of what Adimmune Corp is worth, separate from its market price. There are two main types of Adimmune Corp's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Adimmune Corp's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Adimmune Corp's stock to identify patterns and trends that may indicate its future price movements.
The Adimmune Corp stock is traded in Taiwan on Taiwan Stock Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Adimmune Corp is usually not traded on National Day of the Republic of China. Adimmune Stock trading window is adjusted to Asia/Shanghai timezone.
Adimmune |
Adimmune Stock Analysis Notes
About 17.0% of the company shares are owned by insiders or employees . The book value of Adimmune Corp was presently reported as 14.63. The company last dividend was issued on the 14th of September 2021. Adimmune Corp had 1323:1256 split on the 18th of April 2019. Adimmune Corporation manufactures and sells human vaccines in Taiwan. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan. ADIMMUNE CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. It employs 384 people. For more info on Adimmune Corp please contact ChiHsien Chan at 886 4 2538 1220 or go to https://www.adimmune.com.tw.Adimmune Corp Investment Alerts
| Adimmune Corp generated a negative expected return over the last 90 days | |
| Adimmune Corp has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Adimmune Corp has accumulated about 654.9 M in cash with (480.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76. | |
| Roughly 17.0% of the company shares are owned by insiders or employees |
Adimmune Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 17.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adimmune Corp's market, we take the total number of its shares issued and multiply it by Adimmune Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Adimmune Profitablity
Adimmune Corp's profitability indicators refer to fundamental financial ratios that showcase Adimmune Corp's ability to generate income relative to its revenue or operating costs. If, let's say, Adimmune Corp is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Adimmune Corp's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Adimmune Corp's profitability requires more research than a typical breakdown of Adimmune Corp's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. Technical Drivers
As of the 26th of November, Adimmune Corp shows the Standard Deviation of 1.16, mean deviation of 0.8466, and Risk Adjusted Performance of (0.27). Adimmune Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Adimmune Corp mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Adimmune Corp is priced correctly, providing market reflects its regular price of 21.95 per share.Adimmune Corp Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Adimmune Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Adimmune Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Adimmune Corp Outstanding Bonds
Adimmune Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Adimmune Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Adimmune bonds can be classified according to their maturity, which is the date when Adimmune Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Adimmune Corp Predictive Daily Indicators
Adimmune Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Adimmune Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Adimmune Corp Forecast Models
Adimmune Corp's time-series forecasting models are one of many Adimmune Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Adimmune Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Adimmune Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Adimmune Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Adimmune shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Adimmune Corp. By using and applying Adimmune Stock analysis, traders can create a robust methodology for identifying Adimmune entry and exit points for their positions.
Adimmune Corporation manufactures and sells human vaccines in Taiwan. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan. ADIMMUNE CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. It employs 384 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Adimmune Corp to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Additional Tools for Adimmune Stock Analysis
When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.